Rainer Schulz

Q: What Schools Are Affiliated With Rainer Schulz

Rainer Schulz is affiliated with the following schools: University of California, San Diego, Hannover Medical School, Johns Hopkins University, University of Turin, Technical University of Berlin, University of Giessen, University of Duisburg-Essen

Rainer Schulz's AcademicInfluence.com Rankings

Rainer Schulz

Computer Science

#5133

World Rank

#5423

Historical Rank

Machine Learning

#1247

World Rank

#1267

Historical Rank

Artificial Intelligence

#1477

World Rank

#1506

Historical Rank

Database

#2285

World Rank

#2400

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Rainer Schulz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Rainer Schulz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy (2007) (784)
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning (2007) (768)
Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. (2003) (592)
Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning (2014) (542)
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. (2010) (518)
Red blood cells express a functional endothelial nitric oxide synthase. (2006) (507)
Nitric oxide in myocardial ischemia/reperfusion injury. (2004) (454)
Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. (2000) (445)
Cardioprotection: nitric oxide, protein kinases, and mitochondria. (2008) (441)
Measurement of Regional Myocardial Blood Flow With Multiple Colored Microspheres* (1991) (403)
Coronary microembolization: from bedside to bench and back to bedside. (2009) (401)
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. (2019) (395)
Signal Transducer and Activator of Transcription 3 Is Required for Myocardial Capillary Growth, Control of Interstitial Matrix Deposition, and Heart Protection From Ischemic Injury (2004) (386)
High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor (2006) (374)
TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. (2010) (362)
Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion (2010) (358)
ATP Release From Activated Neutrophils Occurs via Connexin 43 and Modulates Adenosine-Dependent Endothelial Cell Function (2006) (349)
The myocardial JAK/STAT pathway: from protection to failure. (2008) (333)
Loss of cardioprotection with ageing. (2009) (316)
Development of Short‐term Myocardial Hibernation Its Limitation by the Severity of Ischemia and Inotropic Stimulation (1993) (299)
Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. (2005) (297)
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection (2018) (293)
Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection (2010) (279)
Ischemic Postconditioning in Pigs: No Causal Role for Risk Activation (2008) (262)
Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance. (2014) (259)
Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation. (1992) (256)
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations (2010) (246)
Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology (2017) (238)
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. (2013) (236)
Impairment of Diazoxide-Induced Formation of Reactive Oxygen Species and Loss of Cardioprotection in Connexin 43 Deficient Mice (2005) (233)
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) (2017) (228)
Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. (1998) (226)
Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. (1994) (220)
Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue (2017) (219)
Cardioprotection by Ischemic Postconditioning Is Lost in Aged and STAT3-Deficient Mice (2008) (208)
Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury (2012) (207)
Myocardial hibernation: a delicate balance. (2005) (204)
TNFα in myocardial ischemia/reperfusion, remodeling and heart failure (2010) (203)
Ischemic postconditioning: experimental models and protocol algorithms (2009) (201)
Myocardial Dysfunction With Coronary Microembolization: Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor-&agr;, and Sphingosine (2002) (201)
Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms (2008) (201)
Translocation of Connexin 43 to the Inner Mitochondrial Membrane of Cardiomyocytes Through the Heat Shock Protein 90–Dependent TOM Pathway and Its Importance for Cardioprotection (2006) (200)
Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart (2017) (197)
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. (2016) (195)
B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. (2003) (187)
No ischemic preconditioning in heterozygous connexin43-deficient mice (2002) (186)
Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. (1998) (183)
Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection. (2015) (180)
Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. (2007) (173)
Plasma Nitrosothiols Contribute to the Systemic Vasodilator Effects of Intravenously Applied NO: Experimental and Clinical Study on the Fate of NO in Human Blood (2002) (171)
Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. (1998) (170)
Preprocedural Statin Medication Reduces the Extent of Periprocedural Non–Q-Wave Myocardial Infarction (2002) (170)
Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications (2017) (169)
Coronary microembolization. (2001) (168)
The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning (2015) (168)
Coronary Microembolization: the Role of TNF- α in Contractile Dysfunction (2002) (164)
Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria (2009) (159)
Bidirectional Role of Tumor Necrosis Factor-&agr; in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction (2007) (158)
Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. (2000) (156)
Endogenous nitric oxide and myocardial adaptation to ischemia. (2000) (149)
ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies (2014) (146)
Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. (2006) (145)
Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo (2003) (144)
Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. (1999) (143)
Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. (2008) (139)
Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. (2005) (139)
Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake. (2009) (131)
Abnormal Coronary Flow Velocity Reserve After Coronary Intervention Is Associated With Cardiac Marker Elevation (2001) (126)
Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth (2018) (118)
Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. (2004) (118)
Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs (2010) (117)
The Angiotensin II Type 1—Receptor Blocker Candesartan Increases Cerebral Blood Flow, Reduces Infarct Size, and Improves Neurologic Outcome after Transient Cerebral Ischemia in Rats (2004) (116)
Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart. Inotropic responses to postextrasystolic potentiation and intracoronary calcium. (1996) (115)
The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection. (2018) (114)
No loss of cardioprotection by postconditioning in connexin 43-deficient mice (2006) (113)
Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. (2017) (111)
Coronary microembolization: the role of TNF-alpha in contractile dysfunction. (2002) (107)
No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. (1996) (106)
Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart (2017) (106)
The in-situ pig heart with regional ischemia/reperfusion - ready for translation. (2011) (105)
Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption (2012) (105)
Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. (2019) (104)
Mechanisms of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine. (1989) (99)
Positive effects of nitric oxide on left ventricular function in humans. (2006) (99)
Heart rate variability and circulating catecholamine concentrations during steady state exercise in healthy volunteers. (1993) (98)
Connexin 43 in ischemic pre- and postconditioning (2007) (96)
Mitochondrial Cx43 hemichannels contribute to mitochondrial calcium entry and cell death in the heart (2017) (95)
Connexin 43 and ischemic preconditioning. (2004) (93)
Pathophysiology of Myocardial Infarction (2008) (92)
Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs. (2000) (90)
Consequences of Regional Inotropic Stimulation of Ischemic Myocardium on Regional Myocardial Blood Flow and Function in Anesthetized Swine (1989) (89)
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9) (2015) (87)
p38 MAP kinase is a mediator of ischemic preconditioning in pigs. (2002) (87)
Signal transduction of ischemic preconditioning. (1997) (86)
Effects of P2Y12 receptor antagonists beyond platelet inhibition – comparison of ticagrelor with thienopyridines (2016) (85)
Tumor Necrosis Factor-&agr; and Its Receptors 1 and 2: Yin and Yang in Myocardial Infarction? (2009) (85)
Reduced coronary and inotropic reserves with coronary microembolization. (2002) (82)
Endotoxin and ischemic preconditioning: TNF-α concentration and myocardial infarct development in rabbits. (1999) (81)
Pharmacological modulation of connexin‐formed channels in cardiac pathophysiology (2011) (80)
Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. (2003) (80)
Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. (1999) (79)
The coronary circulation in cardioprotection: more than just one confounder. (2012) (77)
No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine. (2000) (77)
The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation. (2013) (77)
Involvement of endogenous adenosine in ischaemic preconditioning in swine (1995) (74)
Time course and mechanisms of contractile dysfunction during acute myocardial ischemia. (1993) (74)
Vasoconstrictor Potential of Coronary Aspirate From Patients Undergoing Stenting of Saphenous Vein Aortocoronary Bypass Grafts and Its Pharmacological Attenuation (2011) (74)
Monoamine Oxidases Are Mediators of Endothelial Dysfunction in the Mouse Aorta (2013) (72)
Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications (2018) (71)
Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes. (2010) (71)
TNF-alpha antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits. (2003) (71)
Glucocorticoid Treatment Prevents Progressive Myocardial Dysfunction Resulting From Experimental Coronary Microembolization (2004) (71)
Formation of reactive oxygen species at increased contraction frequency in rat cardiomyocytes. (2006) (71)
Cellular pathophysiology and therapy of pulmonary hypertension. (2001) (70)
Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. (2010) (70)
Changes of left ventricular diastolic function in exercising dogs without and with ischemia. (1990) (70)
Intraischemic preconditioning. Increased tolerance to sustained low-flow ischemia by a brief episode of no-flow ischemia without intermittent reperfusion. (1995) (70)
Inhibition of the Na+/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits. (2004) (70)
Novel therapeutic strategies for cardioprotection. (2014) (70)
No Effect of Coronary Perfusion on Regional Myocardial Function Within the Autoregulatory Range in Pigs: Evidence Against the Gregg Phenomenon (1991) (67)
The contribution of reactive oxygen species and p38 mitogen‐activated protein kinase to myofilament oxidation and progression of heart failure in rabbits (2010) (66)
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease (2017) (65)
Mitochondria "THE" target of myocardial conditioning. (2018) (65)
Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress. (2016) (64)
S-nitrosation of mitochondrial connexin 43 regulates mitochondrial function (2014) (63)
Nuclear-encoded mitochondrial proteins and their role in cardioprotection. (2011) (63)
Connexin 43 signalling and cardioprotection (2005) (62)
Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT1‐receptor antagonism (2000) (62)
Effect of hypercholesterolaemia on myocardial function, ischaemia–reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning (2017) (61)
Hibernating myocardium: a review. (1996) (61)
Connexin 43 and Mitochondria in Cardiovascular Health and Disease. (2017) (60)
Characteristics of regional myocardial stunning after exercise in dogs with chronic coronary stenosis. (1989) (60)
TNFα in ischemia/reperfusion injury and heart failure (2003) (60)
Connexin 43 impacts on mitochondrial potassium uptake (2013) (59)
AT1 receptor blockade in experimental myocardial ischemia/reperfusion (2003) (58)
Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. (2011) (58)
Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation. (2010) (58)
AP39, a mitochondria‐targeting hydrogen sulfide (H2S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling (2017) (58)
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients (2011) (58)
Nitrite in organ protection (2014) (57)
Inducible Nitric Oxide Synthase Expression and Cardiomyocyte Dysfunction During Sustained Moderate Ischemia in Pigs (2008) (57)
Mitochondria in postconditioning. (2011) (55)
Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia. (2007) (52)
Hypoxia–reoxygenation‐induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase (2013) (51)
New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases (2017) (51)
Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs. (2001) (50)
Characterization of hibernating and stunned myocardium. (1994) (49)
TNFalpha in ischemia/reperfusion injury and heart failure. (2004) (48)
Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure (2016) (46)
From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research” (2016) (46)
The role of mitochondrial reactive oxygen species, NO and H2S in ischaemia/reperfusion injury and cardioprotection (2020) (46)
cAMP controls the restoration of endothelial barrier function after thrombin‐induced hyperpermeability via Rac1 activation (2014) (46)
Inorganic phosphate content and free energy change of ATP hydrolysis in regional short-term hibernating myocardium. (1998) (46)
Regional short-term myocardial hibernation in swine does not involve endogenous adenosine or KATP channels. (1995) (46)
MicroRNA expression profile of human advanced coronary atherosclerotic plaques (2018) (45)
Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia–reperfusion injury: current knowledge (2012) (45)
Functional Genomics of Cardioprotection by Ischemic Conditioning and the Influence of Comorbid Conditions: Implications in Target Identification. (2015) (45)
Expression of calcium regulatory proteins in short-term hibernation and stunning in the in situ porcine heart. (1998) (45)
Perfusion-contraction match and mismatch (2001) (45)
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial. (2019) (44)
Effects of air pollution particles (ultrafine and fine particulate matter) on mitochondrial function and oxidative stress - Implications for cardiovascular and neurodegenerative diseases. (2020) (44)
Responses of chronically hypoxic rat hearts to ischemia: KATP channel blockade does not abolish increased RV tolerance to ischemia. (2004) (43)
Pharmacological Intervention to Modulate HDL: What Do We Target? (2018) (43)
Improving Translational Research in Sex-specific Effects of Comorbidities and Risk Factors in Ischemic Heart Disease and Cardioprotection: Position Paper and Recommendations of the ESC Working Group on Cellular Biology of the Heart. (2020) (42)
No ischemic preconditioning in heterozygous connexin 43-deficient mice (2003) (42)
Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. (2006) (42)
Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way (2017) (42)
Remote preconditioning. (2002) (42)
Connexin43 and ischemic preconditioning. (2006) (42)
Oxidative stress and inflammation contribute to traffic noise-induced vascular and cerebral dysfunction via uncoupling of nitric oxide synthases (2020) (41)
Pleiotropic effects of statins: acutely good, but chronically bad? (2005) (41)
Serum but not myocardial TNF-alpha concentration is increased in pacing-induced heart failure in rabbits. (2003) (41)
PCSK9 targets important for lipid metabolism (2017) (41)
Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. (1999) (41)
Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs. (2003) (39)
A radical view on the contractile machinery in human heart failure. (2011) (38)
Mechanisms involved in postconditioning protection of cardiomyocytes against acute reperfusion injury. (2013) (38)
Post-ejection wall thickening as a marker of successful short term hibernation. (1993) (37)
Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction. (2013) (35)
Mitochondrial ion channels as targets for cardioprotection (2020) (35)
"Myocardial stunning" remaining questions. (1998) (35)
Regulation and role of the presynaptic and myocardial Na+/H+ exchanger NHE1: effects on the sympathetic nervous system in heart failure. (2007) (35)
Noninvasive detection of early pulmonary vascular dysfunction in scleroderma. (2009) (34)
Integrity of sympathetic neurotransmission in stunned myocardium (1988) (34)
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action (2021) (34)
P66shc and its role in ischemic cardiovascular diseases (2019) (34)
Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol. (1995) (34)
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action (2021) (34)
Involvement of endogenous prostaglandins in ischemic preconditioning in pigs. (2002) (34)
Ageing, sex, and cardioprotection (2019) (34)
Prevention of the ischemia-induced decrease in mitochondrial Tom20 content by ischemic preconditioning. (2006) (34)
Connexin 43 and ischemic preconditioning: effects of age and disease (2006) (33)
Interaction between Connexin 43 and nitric oxide synthase in mice heart mitochondria (2015) (33)
Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study (2014) (33)
Positron emission tomography analysis of [1-(11)C] acetate kinetics in short-term hibernating myocardium. (1998) (32)
No ischemic preconditioning in heterozygous connexin 43-deficient mice--a further in vivo study. (2003) (32)
Ischemia and reperfusion related myocardial inflammation: A network of cells and mediators targeting the cardiomyocyte (2015) (32)
Specific Mechanisms Underlying Right Heart Failure: The Missing Upregulation of Superoxide Dismutase-2 and Its Decisive Role in Antioxidative Defense. (2015) (32)
Attenuation of myocardial stunning by the AT1 receptor antagonist candesartan (1999) (31)
Influence of mental stress and environmental toxins on circadian clocks: Implications for redox regulation of the heart and cardioprotection (2019) (31)
Peroxynitrite: toxic or protective in the heart? (2001) (31)
CORDAT II: a new program for data acquisition and on-line calculation of hemodynamic and regional myocardial dimension parameters. (1993) (31)
NOX4 in Mitochondria: Yeast Two-Hybrid-Based Interaction with Complex I Without Relevance for Basal Reactive Oxygen Species? (2015) (30)
The relationship between regional blood flow and contractile function in normal, ischemic, and reperfused myocardium (1998) (30)
Coronary microembolization does not induce acute preconditioning against infarction in pigs-the role of adenosine. (2004) (29)
'Myocardial hibernation'--questions and controversies. (1997) (29)
Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop (2012) (29)
The gap junction modifier ZP1609 decreases cardiomyocyte hypercontracture following ischaemia/reperfusion independent from mitochondrial connexin 43 (2017) (29)
Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects (2014) (28)
Hyperlipidaemia and cardioprotection: Animal models for translational studies (2019) (28)
TNFalpha in myocardial ischemia/reperfusion: damage vs. protection. (2008) (28)
Stress kinase phosphorylation is increased in pacing-induced heart failure in rabbits. (2003) (28)
The stress-responsive MAP kinase p38 is activated by low-flow ischemia in the in situ porcine heart. (2000) (27)
No impact of protein phosphatases on connexin 43 phosphorylation in ischemic preconditioning. (2008) (27)
Cx43 hemichannel microdomain signaling at the intercalated disc enhances cardiac excitability. (2021) (27)
Progressive loss of perfusion-contraction matching during sustained moderate ischemia in pigs. (2001) (27)
RyR2 regulates Cx43 hemichannel intracellular Ca2+-dependent activation in cardiomyocytes. (2019) (27)
The biology of myocardial hibernation. (2000) (26)
Glycogen synthase kinase 3β transfers cytoprotective signaling through connexin 43 onto mitochondrial ATP-sensitive K+ channels (2011) (26)
Interaction of the heart and its close and distant neighbours: report of the Meeting of the ESC Working Groups Myocardial Function and Cellular Biology. (2013) (26)
Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart (2015) (26)
AT1-receptor blockade in experimental myocardial ischemia/reperfusion. (2003) (25)
Mitochondrial respiratory states and rates (2019) (25)
Activation of ATP‐dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs (2002) (25)
In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature (2017) (24)
Endothelial Mesenchymal Transition in Hypoxic Microvascular Endothelial Cells and Paracrine Induction of Cardiomyocyte Apoptosis Are Mediated via TGFβ1/SMAD Signaling (2017) (24)
Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination An experimental study in rats (2006) (24)
No importance of TNFa in classic ischemic preconditioning (2002) (23)
Exacerbation of adverse cardiovascular effects of aircraft noise in an animal model of arterial hypertension (2020) (23)
Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors. (2019) (23)
Minimal α1- and α2-adrenoceptor-mediated coronary vasoconstriction in the anaesthetized swine (1990) (23)
Mechanism and consequences of the shift in cardiac arginine metabolism following ischaemia and reperfusion in rats (2014) (23)
Mechanosensitive release of parathyroid hormone-related peptide from coronary endothelial cells. (2002) (22)
The cellular prion protein counteracts cardiac oxidative stress. (2014) (22)
Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity (2007) (22)
The role of heart rate and the benefits of heart rate reduction in acute myocardial ischaemia (2007) (22)
Unique cardioprotective action of the new calcium antagonist mibefradil. (1999) (21)
Diastolic dysfunction of stunned myocardium. (1991) (21)
No involvement of nitric oxide in the limitation of beta-adrenergic inotropic responsiveness during ischemia. (2001) (21)
Cardiomyocyte ageing and cardioprotection: Consensus Document from the ESC Working Groups Cell Biology of the Heart and Myocardial Function. (2020) (21)
Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation (2006) (21)
Inflammatory markers in coronary heart disease: coronary vascular versus myocardial origin? (2003) (21)
Minimal protection of the liver by ischemic preconditioning in pigs. (2001) (21)
Mitochondrial respiration and membrane potential after low-flow ischemia are not affected by ischemic preconditioning. (2007) (21)
No attenuation of ischaemic preconditioning by the calcium antagonist nisoldipine. (1996) (20)
Preinfarction angina: no interference of coronary microembolization with acute ischemic preconditioning. (2005) (20)
[Poor reproducibility of parameters of heart rate variations]. (1992) (20)
Effect of NO synthase inhibition on myocardial metabolism during moderate ischemia. (2003) (20)
Hibernating myocardium: new answers, still more questions! (2002) (19)
Review on Chamber-Specific Differences in Right and Left Heart Reactive Oxygen Species Handling (2018) (19)
Connexin 43 phosphorylation by casein kinase 1 is essential for the cardioprotection by ischemic preconditioning (2021) (19)
AIM2-driven inflammasome activation in heart failure. (2021) (19)
Influence of cardiometabolic comorbidities on myocardial function, infarction, and CARDIOPROTECTION: Role of cardiac redox signaling. (2021) (18)
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial. (2016) (18)
Survival pathways in cardiac conditioning: individual data vs. meta-analyses. What do we learn? (2017) (18)
Lack of Contribution of p66shc and Its Mitochondrial Translocation to Ischemia-Reperfusion Injury and Cardioprotection by Ischemic Preconditioning (2017) (18)
Cardioprotection by Ivabradine Through Heart Rate Reduction and Beyond (2011) (17)
Preservation of peripheral vasodilation as a surrogate of cardioprotection? The mechanistic role of ATP-dependent potassium channels and the mitochondrial permeability transition pore. (2011) (17)
COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart. (2021) (17)
Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial K(ATP) channels in mouse cardiomyocytes. (2010) (17)
X-ray densitometry for the measurement of regional myocardial perfusion (2000) (17)
Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study (2017) (17)
Reduced calcium responsiveness characterizes contractile dysfunction following coronary microembolization (2008) (17)
CTRP9 Mediates Protective Effects in Cardiomyocytes via AMPK- and Adiponectin Receptor-Mediated Induction of Anti-Oxidant Response (2020) (17)
Heart rate reduction improves myocardial ischemia in swine: role of interventricular blood flow redistribution. (1991) (16)
Purinergic Regulation of Endothelial Barrier Function (2021) (16)
Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors. (2013) (16)
Protection against pressure overload-induced right heart failure by uncoupling protein 2 silencing (2019) (15)
Does a relative perfusion measure predict cerebral infarct size? (2005) (15)
Regional differences of myocardial infarct development and ischemic preconditioning (2004) (15)
Quantification of cardioprotective gene expression in porcine short-term hibernating myocardium. (1999) (15)
Inhibition of Na+/H+‐exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial β‐adrenoceptor system in failing rabbit hearts (2006) (15)
Myocardial hibernation: adaptation to ischaemia. (1996) (14)
Thiol-based redox-active proteins as cardioprotective therapeutic agents in cardiovascular diseases (2021) (14)
Neglect of the coronary circulation: some critical remarks on problems in the translation of cardioprotection. (2009) (14)
C-reactive protein: just a biomarker of inflammation or a pathophysiological player in myocardial function and morphology? (2011) (14)
Does nitric oxide signaling differ in pre- and post-conditioning? Importance of S-nitrosylation vs. protein kinase G activation. (2013) (14)
Characterization of hibernating and stunned myocardium. (1995) (13)
Selegiline reduces adiposity induced by high‐fat, high‐sucrose diet in male rats (2018) (13)
Impaired resting perfusion in viable myocardium distal to chronic coronary stenosis in rats. (2005) (13)
Evaluation of parameters for the assessment of regional myocardial contractile function during asynchronous left ventricular contraction (1990) (13)
The relation of contractile function to myocardial perfusion (1999) (13)
PCSK9 in Myocardial Infarction and Cardioprotection: Importance of Lipid Metabolism and Inflammation (2020) (13)
Cardiomyocyte-specific deletion of survivin causes global cardiac conduction defects (2012) (13)
Inhibition of peroxynitrite-induced dityrosine formation with oxidized and reduced thiols, nitric oxide donors, and purine derivatives. (2001) (13)
Nagarse treatment of cardiac subsarcolemmal and interfibrillar mitochondria leads to artefacts in mitochondrial protein quantification. (2018) (12)
Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” [Redox Biol. 13 (2017) 94–162] (2017) (12)
Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion (2020) (12)
Identification of Necrotic Tissue by Phase–Contrast Microscopy at an Early Stage of Acute Myocardial Infarction (2000) (12)
Pressure-flow characteristics in the right and left ventricular perfusion territories of the right coronary artery in swine (1991) (12)
Importance of Cx43 for Right Ventricular Function (2021) (12)
Minimal alpha 1- and alpha 2-adrenoceptor-mediated coronary vasoconstriction in the anaesthetized swine. (1990) (11)
Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply. (2017) (11)
Effect of ticagrelor on endothelial calcium signalling and barrier function (2016) (11)
Alterations in Glucose Metabolism During the Transition to Heart Failure: The Contribution of UCP-2 (2020) (11)
Hibernating myocardium (2000) (11)
Reduction of Cerebral Infarct Size by Dronedarone (2011) (11)
Endogenous Protective Mechanisms in Myocardial Ischemia: Hibernation and Ischemic Preconditioning (1997) (11)
JDP2 overexpression provokes cardiac dysfunction in mice (2018) (11)
Pathophysiology of hibernation, stunning, and ischemic preconditioning. (1998) (10)
Mitochondrial potassium homeostasis: a central player in cardioprotection. (2016) (10)
Transcriptional Alterations by Ischaemic Postconditioning in a Pig Infarction Model: Impact on Microvascular Protection (2019) (10)
Autocrine effects of PCSK9 on cardiomyocytes (2020) (10)
Cardiomyocytes-specific deletion of monoamine oxidase B reduces irreversible myocardial ischemia/reperfusion injury. (2021) (10)
Compound C inhibits in vitro angiogenesis and ameliorates thrombin-induced endothelial barrier failure. (2015) (10)
Impact of resting and ischemic blood flow on infarct probability in ischemic preconditioning--a new approach to infarct size-blood flow data by logistic regression. (1998) (10)
Vascular and cardiac oxidative stress and inflammation as targets for cardioprotection. (2021) (10)
Interrelation between end-systolic pressure-volume and pressure-wall thickness relations. (1988) (10)
Mesenteric ischemia-reperfusion injury: clearly improved hemodynamics but only minor protection of the rat small intestine by (sub)therapeutic heparin sodium and enoxaparin doses. (2013) (10)
Stunned myocardium: inotropic reserve and pharmacological attenuation (1995) (10)
Ischaemic post‐conditioning in rats: Responder and non‐responder differ in transcriptome of mitochondrial proteins (2020) (10)
Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature (2017) (9)
Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities. (2018) (9)
An easy and quick implantation procedure for the measurement of myocardial wall thickness using sonomicrometry (1987) (9)
Less afterload sensitivity in short-term hibernating than in acutely ischemic and stunned myocardium. (2000) (8)
Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis (2022) (8)
A new paradigm: cross talk of protein kinases during reperfusion saves life! (2005) (8)
Old and new biomarkers of oxidative stress in heart failure (2012) (7)
The impact of subarachnoid hemorrhage on regional cerebral blood flow and large-vessel diameter in the canine model of chronic vasospasm. (2007) (7)
Connexin 43 in Mitochondria: What Do We Really Know About Its Function? (2022) (7)
Cardiac miRNA Expression and their mRNA Targets in a Rat Model of Prediabetes (2020) (7)
Differential effects of right and left heart failure on skeletal muscle in rats (2020) (7)
[Coronary microembolization: perfusion-contraction mismatch secondary to myocardial inflammation]. (2004) (7)
Coronary microembolization. (2004) (7)
Selective thromboxane A2 receptor blockade in experimental exercise-induced myocardial ischaemia in dogs. (1989) (7)
Cardioprotection in right heart failure (2020) (7)
Adverse Effects on β‐Adrenergic Receptor Coupling: Ischemic Postconditioning Failed to Preserve Long‐Term Cardiac Function (2017) (7)
Effect of coronary hyperperfusion on regional myocardial function and oxygen consumption of stunned myocardium in pigs (1991) (7)
[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia]. (2009) (7)
Redox Regulatory Changes of Circadian Rhythm by the Environmental Risk Factors Traffic Noise and Air Pollution (2022) (7)
Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes (2021) (6)
Impact of PCSK9 on CTRP9-Induced Metabolic Effects in Adult Rat Cardiomyocytes (2021) (6)
Pathophysiology of coronary microembolisation (2003) (6)
Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension. (2021) (6)
Features of short-term myocardial hibernation (1998) (6)
Connexins in cardiac ischemia (2018) (6)
Risk factors, co‐morbidities, and co‐medications in cardioprotection: Importance for translation (2020) (6)
Genetic Deletion of p66shc and/or Cyclophilin D Results in Decreased Pulmonary Vascular Tone. (2020) (5)
Pharmacological mechanisms to attenuate sympathetically induced myocardial ischemia (2005) (5)
Pleiotropic Effects of Dronedarone on Ischemia/Reperfusion Injury in Heart and Brain (2012) (5)
Circadian rhythms in ischaemic heart disease. Key aspects for preclinical and translational research: Position paper of the ESC Working Group on Cellular Biology of the Heart. (2021) (5)
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning (2022) (5)
Structural, Pro-Inflammatory and Calcium Handling Remodeling Underlies Spontaneous Onset of Paroxysmal Atrial Fibrillation in JDP2-Overexpressing Mice (2020) (5)
Brady cardie Agent UL‐FS 49 Attenuates Ischemic Regional Myocardial Dysfunction and Reduces Infarct Size in Swine: Comparison with the β‐Blocker Atenolol (1995) (5)
l‐Arginine preferentially dilates stenotic segments of coronary arteries thereby increasing coronary flow (2008) (5)
AJP MS H-00902-2002-R1 FINAL ACCEPTED VERSION B-TYPE NATRIURETIC PEPTIDE (BNP) LIMITS INFARCT SIZE IN RAT ISOLATED HEART VIA KATP CHANNEL OPENING (2003) (5)
Myocardial hibernation – adaptation to ischemia (2000) (5)
Endogenous protective mechanisms in myocardial ischemia: hibernation and ischemic preconditioning. (1994) (5)
Dynamische Hyperinflation bei der pulmonal arteriellen Hypertonie: „Hyperinflator“ und „Non-Hyperinflator“ (2013) (5)
Acute adaptation to ischemia: Short-term hibernating myocardium (2004) (4)
Ischemic postconditioning's cardioprotection is lost in aged and STAT3-deficient mice (2007) (4)
Ischemic preconditioning and myocardial hibernation: Is there a common mechanism? (1996) (4)
Lack of Contribution of p66shc to Pressure Overload-Induced Right Heart Hypertrophy (2020) (4)
Chronic Treatment with Fluvastatin Improves Smooth Muscle Dilatory Function in Genetically Determined Hyperlipoproteinemia (2004) (4)
Little Evidence for Lethal Reperfusion Injury to Cardiomyocytes (2004) (4)
Balance and imbalance of regional myocardial contractile function and blood flow (2001) (4)
Extracellular adenosine attenuates left ventricular hypertrophy through its impact on the protein kinase and phosphatase interaction. (2008) (4)
Postconditioning reduces infarct size after ischemia/reperfusion in pigs (2007) (4)
The role of gasotransmitters (2014) (4)
[The pathophysiology of myocardial circulation. I. Adaptation to myocardial ischemia (the "hibernating" myocardium)]. (2009) (4)
Interventricular redistribution of myocardial blood flow during metabolic vasodilation (2004) (4)
[Pathophysiology of myocardial blood flow. II. Postischemic contractile dysfunction ("stunned" myocardium)]. (2009) (3)
Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection (2021) (3)
Position Paper of the ESC Working Group Cellular Biology of the Heart : Cell-Based Therapies for Myocardial Repair and Regeneration in Ischemic Heart Disease and Heart Failure (2016) (3)
Transcutaneous pCO2-monitoring for the evaluation of the anaerobic threshold. Comparison to lactate and ventilatory thresholds. (1993) (3)
[Pathophysiology of the "hibernating" myocardium]. (1995) (3)
[Ischemic pre- and postconditioning]. (2006) (3)
Hibernation or repetitive stunning -does it matter? The basic perspective (2009) (3)
Editorial: Special Issue "Implications of oxidative stress and redox biochemistry for heart disease and cardioprotection - The EU-CARDIOPROTECTION COST Action (CA16225)". (2021) (3)
[Pathophysiology of the renin-angiotensin-system in atrial fibrillation]. (2006) (3)
Angiotensin II in the Failing Heart (2006) (3)
Targeted Mito- and Cardioprotection by Malonate. (2022) (3)
Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart. (2015) (3)
Effect of nitric oxide deficiency on the pulmonary PTHrP system (2016) (3)
PI3K as Mediator of Apoptosis and Contractile Dysfunction in TGFβ1-Stimulated Cardiomyocytes (2021) (3)
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Deletion but Not Inhibition of Extracellular PCSK9 Reduces Infarct Sizes Ex Vivo but Not In Vivo (2022) (3)
No impairment of sympathetic neurotransmission in stunned myocardium. (1990) (3)
Mitochondrias' sense of SNO: pathway to cardioprotection in ischaemic preconditioning. (2015) (3)
Recruitment of an Inotropic Reserve in Hibernating and Stunned Myocardium (1992) (2)
The regulation and control of mitochondrial homeostasis in changing cardiac tolerance to ischemia-reperfusion injury: a focused issue (2009) (2)
Molecular Network Approach Reveals Rictor as a Central Target of Cardiac ProtectomiRs (2021) (2)
AT1 receptor blockade in experimental myocardial ischemia/reperfusion. (1998) (2)
Signal transducer and activator of transcription 3 is located in the matrix of cardiomyocyte mitochondria (2008) (2)
Retraction for Rottlaender et al., Glycogen synthase kinase 3β transfers cytoprotective signaling through connexin 43 onto mitochondrial ATP-sensitive K+ channels (2012) (2)
Myocardial hibernation. (2002) (2)
Cardioplegia and cardiac function (1993) (2)
Preface to mitochondria and cardioprotection. (2011) (2)
Yin and Yang in Myocardial Infarction? (2009) (2)
Linear and non-linear dynamics of heart rate variability in brain dead organ donors (2001) (2)
Effects of Verapamil and Mibefradil on Regional Blood Flow and Function in Normal and Ischemic Myocardium (1999) (2)
[Chronic myocardial ischemia--hibernating myocardium: characteristics and limits]. (1993) (1)
Mitochondrial connexin 43 hemichannels (2007) (1)
Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion (2001) (1)
AMPK Activation Is Indispensable for the Protective Effects of Caloric Restriction on Left Ventricular Function in Postinfarct Myocardium (2022) (1)
P269Hearts subjected to ischemia-reperfusion benefit from adenine nucleotide translocase 1 overexpression (2018) (1)
Platelet inhibitors influence cardioprotection: importance in preclinical study design: reply. (2015) (1)
Interference with the renin-angiotensin system in heart failure (2006) (1)
Angiotensin II in the failing heart. Short communication. (2005) (1)
Pathophysiologie von Hibernation, Stunning und Ischemic Preconditioning (1998) (1)
Abstract 1290: Connexin 43 Controls Mitochondrial Respiration (2006) (1)
Dobutamine induces a biphasic response in dysfunctional left ventricular regions. (1996) (1)
New Paradigms of Coronary Artery Disease (1996) (1)
[Pathophysiology of myocardial circulation. III. Preliminary results of ischemia using ischemia ("ischemic preconditioning")]. (2009) (1)
Abstract 414: Connexin43 in the Inner Mitochondrial Membrane of Cardiomyocytes Forms Hemichannels that Contribute to Matrix Volume Regulation (2007) (1)
Abstract 1595: Orientation of Connexin 43 in the Inner Mitochondrial Membrane and its Role in Respiration (2008) (1)
Primordial non-responsiveness: a neglected obstacle to cardioprotection. (2023) (1)
Cardioprotective efficacy of limb remote ischemic preconditioning in rats: discrepancy between meta-analysis and a three-centre in vivo study. (2023) (1)
Overview of contemporary reperfusion strategies in acute ST-elevation myocardial infarction (2005) (1)
Editorial: Ischemic preconditioning (2000) (1)
Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost (2022) (1)
Induction of Proteasome Subunit Low Molecular Weight Protein (LMP)-2 Is Required to Induce Active Remodeling in Adult Rat Ventricular Cardiomyocytes (2020) (1)
Does ischemic preconditioning require reperfusion before index ischemia? (2000) (1)
Induced Pluripotent Stem Cells for Cardiac Regeneration (2016) (1)
Swiprosin-1/EFhD-2 Expression in Cardiac Remodeling and Post-Infarct Repair: Effect of Ischemic Conditioning (2020) (1)
Quinidine Attenuates Sympathetically Induced Poststenotic Myocardial Ischemia (1987) (1)
Oxidative Stress and Nitrosative Stress (2016) (1)
Mitochondrial Monoamine Oxidase: Another Player in Pulmonary Hypertension? (2020) (1)
Recovery from reversible myocardial ischemic injury (1998) (1)
‘ ‘ Myocardial stunning ’ ’ remaining questions 1 (1998) (0)
No importance of TNFalpha in classic ischemic preconditioning (2002) (0)
The myocardial TNFα-concentration is not increased during pacing-induced heart failure in rabbits (2001) (0)
Editorial Commentary C-Reactive Protein Just a Biomarker of Inflammation or a Pathophysiological Player in Myocardial Function and Morphology? (2011) (0)
Adaptation an Myokardischämie: „hibernating myocardium“ (1995) (0)
Regional function, metabolism and morphology in ischemic myocardium during continuous inotropic stimulation with dobutamine (1992) (0)
Delayed myocardial protection following coronary microembolization is mediated by TNF-α (2006) (0)
Stem Cell Biology (2005) (0)
Sarcolemmal and mitochondrial connexin 43 protein contents are reduced in aged mouse myocardium (2006) (0)
Abstract 3926: Effect of Replacing Cx43 With Cx32 on Myocardial Energetics and Preconditioning Protection (2009) (0)
Improvement of myocardial blood flow and function and infarct size reduction by heart rate reduction with Ivabradine (2008) (0)
Ischemic preconditioning attenuates the dephosphorylation of connexin 43 in pigs in situ (2002) (0)
Characterization of hibernating and stunned myocardium. (1994) (0)
JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation? (2021) (0)
Subject Index Vol. 28, 2005 (2006) (0)
Commentary on “Nitric oxide synthase-derived plasma nitrite predicts exercise capacityNitric oxide synthase-derived plasma nitrite predicts exercise capacity” (2007) (0)
Importance of Mitochondria in Cardiac Pathologies: Focus on Uncoupling Proteins and Monoamine Oxidases (2023) (0)
[Physiopathology of coronary heart disease--therapeutic implications]. (1999) (0)
venulesvasoconstriction in pulmonary arterioles and (2015) (0)
Abstract 3513: STAT3 in the Matrix of Cardiomyocyte Mitochondria Regulates Opening of the Mitochondrial Permeability Transition Pore (2009) (0)
MicroRNA expression profile of human advanced coronary atherosclerotic plaques (2018) (0)
[Short-term hibernating myocardium: circulation, function and metabolism in sustained regional myocardial ischemia]. (1998) (0)
Abstract 1897: Ischemic Postconditioning in Pigs - No RISK Activation beyond that by Immediate Full Reperfusion (2008) (0)
cAMP signalling in endothelial cells: Differential effects on angiogenesis via PKA and Epac signalling (2013) (0)
Workshop : Cardioprotection – from novel targets to clinical application (2016) (0)
Ischemic preconditioning. (2000) (0)
Increase of TNFα-concentration in serum and liver but not in myocardium during pacing-induced heart failure (2002) (0)
Is myocardial stunning due to endopeptidase activation? A clinical study (2002) (0)
Hypoxic preconditioning after short term hypoxia with intermittent normoxia (2005) (0)
GSK3β Transfers Cytoprotective Signaling through Connexin 43 onto Mitochondrial ATP-Sensitive K+ Channels (2012) (0)
Increased myocardial arginase expression in failing hearts (2008) (0)
Hypoxic preconditioning: KATP-channel blockade does not prevent increased right ventricular tolerance to ischemia in hearts of chronically hypoxic rats (2004) (0)
Responses of Chronically Hypoxic Rat Hearts to Ischemia: KATP-Channel Blockade Does Not Abolish Increased Right Ventricular Tolerance to Ischemia (2003) (0)
Connexin 43 is present in subsarcolemmal but not in interfibrillar mitochondria of rat cardiac myocytes (2009) (0)
Sphingosine contributes to tumor necrosis factor-a-mediated contractile dysfunction in response to coronary microembolization (2002) (0)
Abstract 349: Signal Transducer and Activator of Transcription 3 (Stat3) in the Matrix of Cardiomyocyte Mitochondria (2008) (0)
Signal Transduction in Heart Failure: Connexin 43 Expression (2005) (0)
Abstract 13050: S-Nitrosylation of Mitochondrial Connexin 43: A possible Mechanism Mediating Ischemic Preconditioning in Rat Hearts (2013) (0)
p38 MAPK and apoptosis in pacing-induced heart failure in rabbits (2002) (0)
Somatostatin Primes Endothelial Cells for Agonist-Induced Hyperpermeability and Angiogenesis In Vitro (2022) (0)
[Hibernating myocardium: no involvement of endogenous adenosine]. (1996) (0)
Obesity, Fat Tissue Distribution, and Muscle Loss Affect TAVR Short- and Long-Term Morbidity and Mortality (2021) (0)
Myokardiale Mikroinfarkte (2008) (0)
Matrix metalloproteinase 2 acts as repressor hypertrophic growth in ventricular cardiomyocytes of rat (2018) (0)
P4642miRNAs as new cellular monocytic biomarkers of myocardial infarction: pilot study (2017) (0)
Preserved right ventricular function in mitochondrial uncoupling protein 2 deficient mice in pressure overload induced right ventricular insufficiency (2015) (0)
Just a Biomarker of Inflammation or a Pathophysiological Player in Myocardial Function and Morphology? (2011) (0)
1025-45 Preprocedural statin medication reduces small and large periprocedural myocardial injury in patients with stent implantation (2004) (0)
P551Effects of interferon gamma on endothelial barrier function: differential role of classical and non-classical pathways (2018) (0)
The cardiovascular role of proprotein convertase subtilisin/kexin 9 (PCSK9) (2018) (0)
Ascorbic acid inhibits ischemic preconditioning in pigs (2002) (0)
Reduced myocardial calcium responsiveness after coronary microembolization (2007) (0)
Correction (2013) (0)
WITHDRAWN: Reduced myocardial calcium responsiveness after coronary microembolization (2007) (0)
Pulmonary hypertension with 2020 vision (2020) (0)
In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature (2017) (0)
No ischemic preconditioning in heterozygous connexin 43 - knockout mice (2002) (0)
P181cAMP-mediated Rac1 activation regulates the re-establishment of endothelial adherens junctions and barrier restoration during inflammation (2014) (0)
Loss of arachidonic acid is most predominant form plasmenylcholine during ischemia-reperfusion in isolated working rat hearts (1992) (0)
WITHDRAWN: Mitochondrial connexin 43 hemichannels (2007) (0)
[A two-stage regulatory system for pressure-constant perfusion of coronary vessels]. (1991) (0)
P187. Erythrocytes are vasoactive through a functional eNOS (2006) (0)
ischemia and inotropic stimulation Development of short-term myocardial hibernation. Its limitation by the severity of (2011) (0)
Mitochondrial ion channels as targets for cardioprotection Mitochondrial ion channels as targets for cardioprotection. (0)
Parathyroid hormone-related peptide improves myocardial contractile function of stunned myocardium in vivo (2001) (0)
Diastolic dysfunction in prediabetes: role of mitochondrial oxidative stress (2016) (0)
Myocardial Dysfunction With Coronary Microembolization Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor- (cid:1) , and Sphingosine Integrative (2002) (0)
Effects of Bempedoic Acid in Acute Myocardial Infarction in Rats: No Cardioprotection and No Hidden Cardiotoxicity (2023) (0)
Stunning Versus Hibernation Versus Preconditioning : What Is the Difference ? (2008) (0)
P66shc deficient mice develope decreased right heart hypertrophy via a Cyclophilin D dependent mechanism in hypoxia-induced pulmonary hypertension (2014) (0)
Publisher Correction: Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study (2018) (0)
chronic coronary stenosis in rats Impaired resting perfusion in viable myocardium distal to (2016) (0)
Signal Transducer and Activator of Transcription 3 Is Required for Myocardial Capillary Growth, Control of Interstitial Matrix Deposition, and Heart Protection From Ischemic Injury Integrative Physiology (2004) (0)
Focussed Issue: Mitochondria – a matter of life and death (2003) (0)
Rosuvastatin reduces myocardial β-adrenoceptor-density and -high affinity state without functional consequences (2007) (0)
The cardiovascular role of uncoupling protein 2 (Ucp2): Is it cardiac-specific and an uncoupling protein? (2018) (0)
CON: Hibernating myocardium: adaptation to ischaemia (2000) (0)
The progression of contractile dysfunction correlates with the extent of myofibrillar protein oxidation in failing rabbit hearts (2006) (0)
1063-59 Preprocedural statin medication reduces the risk for periprocedural myocardial infarctions in patients with stent implantation independent of the cholesterol level (2004) (0)
EDITORIAL COMMENT Pleiotropic Effects of Statins (2005) (0)
[Pathophysiology of atrial fibrillation: importance of the renin-angiotensin system]. (2006) (0)
Induction of nitric oxide (NO) synthesis in myocardium by endotoxin or cytokines — A possible key to cardiac depression in shock (1992) (0)
Regulation of the pulmonary vascular tone by p66shc and cyclophilin D (2017) (0)
Red blood cells express a functional endothelial nitric oxide synthase. Commentary (2006) (0)
P306Ventricular dysfunction and fibrosis precedes atrial fibrillation in JDP2 overexpression mice (2018) (0)
COVID-19 related cardiac complications – from clinical evidences to basic mechanisms. 2 Opinion paper of the ESC Working Group on Cellular Biology of the Heart 3 (2021) (0)
Nagarse treatment of cardiac subsarcolemmal and interfibrillar mitochondria accounts for inaccurate quantification of proteins (2018) (0)
Modifying Epicardial PCSK9 Expression to Protect Cardiac Function? (2019) (0)
Diastolic dysfunction in short-term hibernating myocardium (1999) (0)
Fat Tissue Distribution and Muscle Loss Affect TAVR Short- and Long-Term Morbidity and Mortality: Predictability by GDF-15 Levels (2022) (0)
P6372Does modification of activity regimes optimize the effect of high physical activity on hypertensive heart disease? (2019) (0)
Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study (2017) (0)
Rictor is a central target of the molecular network of cardiac ProtectomiRs (2022) (0)
Sex Difference in Cardioprotection against Acute Myocardial Infarction in MAO-B Knockout Mice In Vivo (2023) (0)
basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting frontiers in cardiovascular 69-81. (2016) (0)
Cardioprotection by limb remote ischemic preconditioning in rats: discrepancy between meta-analysis and a three-center in vivo study (2022) (0)
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trial. (2022) (0)
junctional and mitochondrial levels of connexin 43 aged mouse hearts is associated with reduced gap Loss of ischemic preconditioning's cardioprotection in (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Rainer Schulz?

Rainer Schulz is affiliated with the following schools:

Rainer Schulz's Academic­Influence.com Rankings

Why Is Rainer Schulz Influential?

Rainer Schulz's Published Works

Published Works

What Schools Are Affiliated With Rainer Schulz?

Rainer Schulz's AcademicInfluence.com Rankings